I need to say this upfront: most companies don’t need a CMO.
They need a marketing strategy. They need someone who can build a system that scales. They need executive-level thinking without the executive-level overhead.
That’s where the fractional CMO model enters. And if you’re running a challenger brand in health, wellness, beauty, or emerging therapeutics, this might be the most strategically sound decision you make this year.
What a Fractional CMO Actually Is
A fractional CMO provides executive-level marketing leadership on a part-time basis. You get the strategic architecture, the frameworks, the decision-making authority. You don’t get the full-time salary, the benefits package, or the 12-month onboarding period.
This isn’t a consultant who shows up with a deck and disappears. This is a marketing executive who operates as part of your leadership team, attends your strategy meetings, manages your agency relationships, and builds the infrastructure your team needs to execute effectively.
The model has exploded over the past few years. The fractional executive market continues to grow as companies recognize that specialized strategic leadership doesn’t require a full-time headcount. For mid-market companies, especially in categories that require regulatory expertise, the fractional model offers something a junior hire never can: pattern recognition across industries and the strategic judgment that comes from building multiple brands.
Why This Model Works for Regulated and Emerging Industries
Here’s where it gets specific. If you’re operating in cannabis, wellness, beauty, or any category where compliance and culture intersect, you don’t just need marketing leadership. You need someone who understands the regulatory landscape, the cultural dynamics, and the commercial realities of building a brand in a space where the rules are still being written.
A fractional CMO who specializes in regulated industries brings a different kind of value:
- They’ve navigated state-by-state compliance in cannabis. They know the difference between what you can say in California versus what you can say in Michigan.
- They understand the tension between clinical credibility and consumer accessibility in wellness. They can bridge the gap between scientific rigor and emotional resonance.
- They’ve built brand systems for multi-state operators, DTC brands, and retail concepts. They know which frameworks scale and which ones break under pressure.
- They’ve managed the cultural sensitivity required to market in emerging therapeutic categories. They understand how to build legitimacy without commoditizing the mission.
This kind of expertise costs $250K-$400K annually at a full-time executive level. At a fractional rate, companies access it for a fraction of that investment while maintaining strategic continuity.
When You Actually Need One
Not every company needs a fractional CMO. Here’s how to know if you do:
You’ve outgrown founder-led marketing. If you’re still the one writing copy, approving ads, and making every marketing decision, you’ve hit the ceiling. Founders running marketing typically stop at a couple million in annual revenue. Beyond that, you need a system.
You’re scaling past your first market. Expansion requires a fundamentally different marketing architecture. What worked in one market won’t automatically translate to another, especially in regulated industries where the rules change by jurisdiction.
You’re burning cash on tactics without strategy. If you’re spending on paid media, content, and events but can’t articulate how those activities connect to your business objectives, you don’t have a marketing plan. You have a spending habit.
You need to professionalize your brand for investors or partners. Institutional investors evaluate brand positioning as part of their due diligence. If your brand can’t articulate a clear competitive position, it affects your valuation.
You’re in a regulated market and can’t afford compliance mistakes. If you’re in cannabis, psychedelics, functional medicine, or any category where compliance constraints shape every marketing decision, you need someone who can translate regulatory limitations into creative opportunities. Healthcare companies grappling with constant regulatory shifts see significant benefit in fractional specialized roles.
You’re repositioning a legacy brand. You’ve been in market for years, but your positioning no longer reflects where the category is moving. You need someone who can rebuild your brand architecture without destroying the equity you’ve already built.
You’re launching into a stigmatized category. Emerging therapeutic industries require a different playbook. You can’t market psychedelics like you market skincare. You need someone who understands how to build cultural legitimacy while maintaining commercial momentum.
You’re operating across multiple locations. Multi-location retail requires standardized systems that still allow for local market adaptation. A fractional CMO can build the architecture that enables both consistency and flexibility.
What the Engagement Actually Looks Like
A typical fractional CMO engagement runs three to twelve months, depending on the scope:
The first 30 days are diagnostic. You’re auditing the brand, the competitive landscape, the current marketing infrastructure, and the team’s capabilities. You’re identifying the gaps between where the company is and where it needs to be.
Days 30-90 are architectural. You’re building the positioning framework, the messaging hierarchy, the channel strategy, and the measurement systems. You’re establishing the strategic foundation that all execution will be built on.
Days 90+ are about execution and optimization. You’re overseeing the implementation of the strategy, managing agency relationships, coaching the internal team, and iterating based on performance data.
The deliverables are tangible: brand positioning documents, messaging frameworks, channel strategies, campaign architectures, team development plans, and measurement dashboards.
This isn’t theoretical. It’s operational. And it’s designed to build enough internal capability that the company can eventually transition to a full-time hire or self-sustaining marketing function.
What It’s Not
A fractional CMO is not an agency replacement. Agencies execute. A fractional CMO provides the strategic direction that makes agency work effective. If you don’t have strategy, adding more agency capacity just produces more unfocused output.
It’s not a marketing manager with a better title. The difference is strategic authority and executive experience. A fractional CMO makes decisions about resource allocation, team structure, and strategic direction. They’re accountable for marketing’s contribution to business growth, not just campaign performance.
It’s not a band-aid for deeper organizational problems. If your product doesn’t work, your operations are dysfunctional, or your leadership team is misaligned on the company’s direction, no amount of marketing leadership will fix that.
It’s not a way to avoid making hard decisions. A good fractional CMO will force you to confront the gaps in your strategy, the weaknesses in your positioning, and the misalignments in your team structure.
And it’s not a long-term solution for companies that need full-time executive leadership. If you’re at the stage where you need a CMO in every leadership meeting, making hiring decisions across multiple departments, and managing a team of 15 people, you need a full-time hire.
The fractional model works best for companies in transition: scaling past founder-led marketing but not yet ready for a full-time executive, navigating a category shift that requires specialized expertise, or rebuilding marketing infrastructure after a period of rapid growth.
The Strategic Inflection Point
A 2024 survey of 340 startup and SMB executives found 9% were working with a fractional CMO, and 22% were actively considering it. That number will accelerate as more companies recognize that strategic marketing leadership is a competitive advantage, not a luxury.
For companies in regulated and emerging industries, the calculus is even clearer. The cost of strategic mistakes in cannabis, wellness, or emerging therapeutics is exponentially higher than in conventional consumer goods. One compliance violation, one poorly positioned product launch, one misaligned brand narrative can cost millions in market position and regulatory goodwill.
The question isn’t whether you can afford a fractional CMO. It’s whether you can afford to keep making strategic decisions without one.
Ready to Explore the Model?
If you’re running a $3M-$100M brand in a regulated or high-growth industry and you’re ready to stop guessing at marketing strategy, let’s talk.
I work as a fractional CMO for challenger brands in cannabis, wellness, beauty, and emerging therapeutic categories. The engagement is designed to build strategic infrastructure that scales, not create dependency on external leadership.
Book a strategy call. We’ll assess whether the fractional model fits your growth stage and map what a strategic engagement would look like for your brand.
Because executive-level marketing strategy shouldn’t require executive-level overhead. It just requires the right partner.




Comments +